Definitive Contract HHSN272201800004C
Award Date
3/28/18
Potential Completion Date
3/29/25
Potential Value
$20M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Duke University
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,178,859.14 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Duke University. The contract is for a "NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT". This is a definitive, cost-no-fee contract with a period of performance through December 14, 2024. The contract was awarded on December 22, 2017 and does not have a set-aside...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $21,659,151.36 definitive cost-no-fee contract to Duke University to support the "ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES." This contract, which does not have a set-aside designation, will run through September 18, 2026. Duke University's Office of Research Administration Division will serve as the prime contractor on this...
This is a $28,340,062 cost-no-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Duke University to provide a Nonhuman Primate Core Humoral Immunology Laboratory in support of AIDS vaccine research and development. The contract has a potential performance period through March 2032. The original solicitation, RFP 75N93023R00012, sought a contractor to conduct assays evaluating humoral immune responses in nonhuman primates immunized with...
This federal contract award to Duke University was issued by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The $13,368,236.91 definitive contract is for an "IMMUNOLOGY QUALITY ASSESSMENT PROGRAM" and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor, and the contract has a period of performance ending on September...
This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, for a project titled "FEASIBILITY FOR DEVELOPMENT OF A LIPOSOME/LNP DISPLAYING AN HIV ENV TRIMER PROTEIN AND CONTAINING/INCORPORATING AN MRNA." The award, valued at $5,885,384.00, is a delivery order under a larger Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents...
Duke University has been awarded a cost-no-fee task order valued at $10.38 million by the National Institutes of Health National Institute of Allergy and Infectious Diseases. The task order was issued against Duke University's existing preclinical and translational vaccine development IDIQ with the agency. Under this task order, Duke University will provide services and materials to support in vitro transcription reactions, mRNA purification, and procurement of lipid raw materials for...
This is a $28,098,860.50 Cost No Fee Definitive Contract awarded to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID) for the NIAID Virology Quality Assurance (VQA) program. The contract has no set-aside designation. Under this contract, Duke University, a prominent private research university, will provide various research, laboratory, and quality assurance services to support NIAID's VQA program, which conducts medical research in areas such as virology and...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Duke University for the production of a protein called A. CON-ENV-03 140CF. The contract has a firm fixed price of $149,839.00 and was awarded on May 10, 2012, with a completion date of June 8, 2012. The contract was not set aside for any specific socioeconomic designation. Duke University, through its Office of Research...
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), awarded a $8,082,295.00 definitive cost-no-fee contract to Duke University's Office of Research Administration Division for the project "INNOVATIONS IN FUNCTIONAL B CELL EPITOPE DISCOVERY". The contract, which has no set-aside designation, runs through September 29, 2029. This contract supports discovery and...
This federal contract award, valued at $13,243,407.79, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Duke University's Office of Research Administration Division. The contract, titled "TAS::75 0885::TAS MODELING IMMUNITY FOR BIODEFENSE," is a Definitive Contract with a Cost No Fee pricing type. It has an ultimate completion date of September 29, 2015 and was initially awarded on September 30, 2010....